Katie Jarstad, PA
Physician Assistant · Coeur D Alene, IDNPI 1326099672
Payments from drug & device makers
Across 355 payments — averaging $13.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$987
- GSK$951
- Johnson & Johnson$470
- Pfizer$342
- AstraZeneca$300
- Astellas Pharma US Inc$184
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,69298%
- Education$902%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $987 |
| GSK | 135 | $951 |
| Johnson & Johnson | 13 | $470 |
| Pfizer | 27 | $342 |
| AstraZeneca | 16 | $300 |
| Astellas Pharma US Inc | 6 | $184 |
| Exact Sciences | 7 | $160 |
| Lilly USA, LLC | 10 | $146 |
| Amgen(2 entities) | 9 | $140 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $119 |
| Novo Nordisk | 6 | $106 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| Boston Scientific | 3 | $84 |
| Abbott | 2 | $77 |
| Phathom Pharmaceuticals, Inc. | 10 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Edwards Lifesciences | 2 | $50 |
| Merck | 2 | $46 |
| Dexcom, Inc. | 2 | $42 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Corcept Therapeutics | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Genentech USA, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Bayer | 1 | $16 |
| Organon | 1 | $16 |
| Corium, LLC | 1 | $16 |
| Verona Pharma, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$252
How this compares
$4,782 in reported general payments places this provider in the 90th percentile of 1,027 physician assistant providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $36,853 |
| EliquisApixaban | 52 | $35,448 |
| MounjaroTirzepatide | 27 | $27,115 |
| JardianceEmpagliflozin | 19 | $26,670 |
| OzempicSemaglutide | 27 | $24,221 |
| TrulicityDulaglutide | 15 | $24,004 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,300 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $8,769 |
| MigergotErgotamine Tartrate/Caffeine | 11 | $7,258 |
| SynthroidLevothyroxine Sodium | 53 | $3,613 |
| Celecoxib | 42 | $3,187 |
| Losartan Potassium | 330 | $3,117 |
| Duloxetine Hcl | 140 | $3,095 |
| Rosuvastatin Calcium | 133 | $3,024 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $2,936 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $146 | $51,11942 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $951 | $45,62260 claims |
| PfizerEliquis | $342 | $35,44852 claims |
| Boehringer IngelheimJardiance | $18 | $26,67019 claims |
| Novo NordiskOzempic | $106 | $24,22127 claims |
| AstraZenecaBreztri Aerosphere | $300 | $9,30015 claims |
| AmgenMigergot | $140 | $7,25811 claims |
| AbbVieSynthroid | $987 | $3,61353 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,027 physician assistant providers in Idaho.
Other physician assistant in Coeur D Alene
- Kimberly PortchCoeur D Alene$17K
- Robert CullenCoeur D Alene$11K
- Annalise MabeCoeur D Alene$6K
- Erika ValtinsonCoeur D Alene$6K
- Benjamin KernsBoise$100K
- Brian BizikTwin Falls$81K
- Autumn HeumanBoise$28K
- James WalkerNampa$21K
- Melissa McClenahanMeridian$19K
- Arthur NeaseMeridian$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.